Private Capital's TMO Position Overview
Private Capital (via Private Capital Management, LLC) currently holds 1,389 shares of Thermo Fisher Scientific Inc. (TMO) worth $682,735, representing 0.07% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Private Capital has maintained a strategic position in TMO, demonstrating sustained confidence in this investment. Largest reduction occurred in Q1 2026, reducing 7 shares.
Analysis based on 13F filings available since 2013 Q2
Private Capital's Thermo Fisher Scientific (TMO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Thermo Fisher Scientific (TMO) Trades by Private Capital
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -7 | Reduce 0.50% | 1,389 | $491.53 |
| Q2 2023 | +1,396 | New Buy | 1,396 | $521.75 |
Private Capital's Thermo Fisher Scientific Investment FAQs
Private Capital first purchased Thermo Fisher Scientific Inc. (TMO) in Q2 2023, acquiring 1,396 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Private Capital has held Thermo Fisher Scientific Inc. (TMO) for 12 quarters since Q2 2023.
Private Capital's largest addition to Thermo Fisher Scientific Inc. (TMO) was in Q2 2023, adding 1,396 shares worth $728,363.
According to the latest 13F filing for Q1 2026, Private Capital's firm, Private Capital Management, LLC, owns 1,389 shares of Thermo Fisher Scientific Inc. (TMO), valued at approximately $682,735.
As of the Q1 2026 filing, Thermo Fisher Scientific Inc. (TMO) represents approximately 0.07% of Private Capital's publicly disclosed stock portfolio, making it one of their key holdings.
Private Capital's peak holding in Thermo Fisher Scientific Inc. (TMO) was 1,396 shares, as reported at the end of Q2 2023.